HTG Molecular Diagnostics, Inc. Available-for-sale Securities, Current
HTG Molecular Diagnostics, Inc. had Available-for-sale Securities, Current of $27.61 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesCurrent · last filed 2018-11-08
- 2018-09-30: Available-for-sale Securities, Current $27.61M.
- 2018-06-30: Available-for-sale Securities, Current $34.96M.
- 2018-03-31: Available-for-sale Securities, Current $25.13M.
- 2017-03-31: Available-for-sale Securities, Current $2.61M.
| Period end | Available-for-sale Securities, Current |
|---|---|
| 2018-09-30 | $27.61M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $34.96M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $25.13M 10-Q · filed 2018-05-10 |
| 2017-03-31 | $2.61M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $4.30M 10-K · filed 2018-03-23 |
| 2016-09-30 | $11.10M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $15.41M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $25.23M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $28.20M 10-K · filed 2017-03-23 |
| 2015-09-30 | $28.71M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $18.46M 10-Q · filed 2015-08-07 |